Perspective: The value of patient-reported outcomes in early-phase clinical trials.

The value of patient-reported outcomes in early-phase clinical trials – Nature Medicine (if the link is paywalled, try this one)

Commentary on Twitter

A @NatureMedicine Comment article argues that patient-reported outcomes, if used correctly, can provide preliminary evidence of efficacy and tolerability from a patient perspective, as well as supporting regulatory review. https://t.co/4ztwW76P2T pic.twitter.com/6sFRvswgJ2

— Nature Portfolio (@NaturePortfolio) January 24, 2022